betway必威登陆网址 (betway.com )学报››2024,Vol. 45››Issue (4): 251-256.DOI:10.3969/j.issn.2097-0005.2024.04.011
• 综述 •上一篇
收稿日期:
2023-11-28出版日期:
2024-04-25发布日期:
2024-05-22通讯作者:
史永军Received:
2023-11-28Online:
2024-04-25Published:
2024-05-22Contact:
Yongjun SHI摘要:
门静脉血栓形成(portal vein thrombosis,PVT)是指门静脉主干和肝内门静脉分支内形成的血栓,伴或不伴有肠系膜和脾静脉受累,其特征是门静脉部分或完全闭塞。PVT是肝硬化患者常见而严重的并发症,且发生率与肝硬化和门静脉高压严重程度呈正相关。门静脉血栓形成不仅可以使肝硬化患者肝功能恶化,加重门静脉高压并导致门静脉高压相关的静脉曲张出血,从而增加肝硬化急性失代偿的发生风险,还会增加肝移植手术难度,降低受者生存率。因此,对于PVT的早期预防尤为重要。由于PVT常起病隐匿,早期一般无明显临床症状,根据临床表现很难诊断PVT,因此研究反映潜在血栓形成的血清学指标至关重要。由于Virchow三联征的组成部分,所有静脉血栓形成都是多因素的:高凝状态、内皮损伤和血流量减少。本文就PVT形成的危险因素及早期预测血清学指标的最新研究进行综述。
孙弹弹, 史永军. 门静脉血栓形成因素预测研究进展[J]. betway必威登陆网址 (betway.com )学报, 2024, 45(4): 251-256.
Tantan SUN, Yongjun SHI. Research Progress of Factors Predicting Portal Vein Thrombosis[J]. Journal of ShanDong First Medical University&ShanDong Academy of Medical Sciences, 2024, 45(4): 251-256.
1 | Katsanos K, Al-Lamki SAM, Parthipun A, et al. Peripheral stent thrombosis leading to acute limb ischemia and major amputation: incidence and risk factors in the aortoiliac and femoropopliteal arteries[J].Cardiovasc Intervent Radiol,2017,40(3): 351. |
2 | Kimball AS, Obi AT, Diaz JA, et al. The emerging role of NETs in venous thrombosis and immunothrombosis[J].Front Immunol,2016,7: 236. |
3 | Guo L, Rondina MT. The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases[J].Front Immunol,2019,10: 2204. |
4 | Driever EG, Magaz M, Adelmeijer J, et al. The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study[J].J Thromb Haemost,2022,20(9): 2075. |
5 | Driever EG, von Meijenfeldt FA, Adelmeijer J, et al. Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus[J].Hepatology,2022,75(4): 898. |
6 | Ren WH, Zhang J, Chen YY, et al. Evaluation of coagulation, fibrinolysis and endothelial biomarkers in cirrhotic patients with or without portal venous thrombosis[J].Clin Appl Thromb Hemost,2020,26: 1076029620982666. |
7 | O'Leary JG. Portal vein thrombosis prediction: rebalanced coagulation and rethinking anticoagulation[J].Liver Transpl,2019,25(12): 1741. |
8 | Lu SX, Hu GH, Chen SY, et al. Risk factors of portal vein thrombosis after devascularization treatment in patients with liver cirrhosis: a nested Case-Control study[J].Biomed Res Int,2020,2020: 9583706. |
9 | Serag WM, Mohammed B, Mohamed MM, et al. Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma[J].Heliyon,2020,6(8): e04677. |
10 | Noronha Ferreira C, Marinho RT, Cortez-Pinto H, et al. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study[J].Liver Int,2019,39(8): 1459. |
11 | Wu YY, Li HY, Zhang TS, et al. Splanchnic vein thrombosis in liver cirrhosis after splenectomy or splenic artery embolization: a systematic review and Meta-Analysis[J].Adv Ther,2021,38(4): 1904. |
12 | Zhang Y, Xu BY, Wang XB, et al. Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation[J].Clin Gastroenterol Hepatol,2020,18(11): 2564. |
13 | Ak C, Adali G, Sayar S, et al. Portal vein thrombosis risk factors in liver transplant candidates[J].Hepatol Forum,2022,3(3): 88. |
14 | Intagliata NM, Caldwell SH, Diagnosis TA. Development,and treatment of portal vein thrombosis in patients with and without cirrhosis[J].Gastroenterology,2019,156(6): 1582. |
15 | Stine JG, Wang J, Shah PM, et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study[J].Liver Int,2018,38(1): 94. |
16 | Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol,2009,51(4): 682. |
17 | Under the Auspices of the Italian Association for the Study of liver diseases (AISF) and the italian society of internal medicine (SIMI). Hemostatic balance in patients with liver cirrhosis: report of a consensus conference[J].Dig Liver Dis,2016,48(5): 455. |
18 | Haidl H, Zöhrer E, Pohl S, et al. New insights into neonatal coagulation: normal clot formation despite lower intra-clot thrombin levels[J].Pediatr Res,2019,86(6): 719. |
19 | Gatt A, Riddell A, Calvaruso V, et al. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy[J].J Thromb Haemost,2010,8(9): 1994. |
20 | Kalambokis GN, Oikonomou A, Baltayiannis G, et al. Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis[J].Hepatol Res,2016,46(3): E36. |
21 | Stine JG, Wang J, Shah PM, et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study[J].Liver Int,2018,38(1): 94. |
22 | Robertson B, Urquhart C, Ford I, et al. Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies[J].J Thromb Haemost,2007,5(8): 1679. |
23 | Turon F, Driever EG, Baiges A, et al. Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors[J].J Hepatol,2021,75(6): 1367. |
24 | Nicoară-Farcău O, Soy G, Magaz M, et al. New insights into the pathogenesis, risk factors, and treatment of portal vein thrombosis in patients with cirrhosis[J].Semin Thromb Hemost,2020,46(6): 673. |
25 | Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, et al. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians[J].J Thromb Thrombolysis,2017,44(3): 377. |
26 | Turco L, Garcia-Tsao G. Portal hypertension: pathogenesis and diagnosis[J].Clin Liver Dis,2019,23(4): 573. |
27 | Di Minno MND, Calcaterra I, Lupoli R, et al. Hemostatic changes in patients with COVID-19: a meta-analysis with meta-regressions[J].J Clin Med,2020,9(7): 2244. |
28 | Liu DW, Zhu YB, Chen W, et al. Relationship between the inflammation/immune indexes and deep venous thrombosis (DVT) incidence rate following tibial plateau fractures[J].J Orthop Surg Res,2020,15(1): 241. |
29 | Xing YY, Tian ZB, Jiang YP, et al. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis[J].Ann Med,2022,54(1): 302. |
30 | Zheng Z, Yu QS, Peng H, et al. Research on portal venous hemodynamics and influencing factors of portal vein system thrombosis for wilson's disease after splenectomy[J].Front Surg,2022,9: 834466. |
31 | Watters JM, Sambasivan CN, Zink K, et al. Splenectomy leads to a persistent hypercoagulable state after trauma[J].Am J Surg,2010,199(5): 646. |
32 | Kinjo N, Kawanaka H, Akahoshi T, et al. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension[J].Br J Surg,2010,97(6): 910. |
33 | Qi XS, Han GH, Ye C, et al. Splenectomy causes 10-Fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J].Med Sci Monit,2016,22: 2528. |
34 | Han JB, Shu QH, Zhang YF, et al. Predictive value of inflammation biomarkers in patients with portal vein thrombosis[J].J Clin Transl Hepatol,2021,9(3): 384. |
35 | Kushnir M, Cohen HW, Billett HH. Persistent neutrophilia is a marker for an increased risk of venous thrombosis[J].J Thromb Thrombolysis,2016,42(4): 545. |
36 | Jiménez-Alcázar M, Kim N, Fuchs TA. Circulating extracellular DNA: cause or consequence of thrombosis?[J].Semin Thromb Hemost,2017,43(6): 553. |
37 | Hilscher MB, Sehrawat T, Arab JP, et al. Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension[J].Gastroenterology,2019,157(1): 193. |
38 | Pan JH, Wang L, Gao FB, et al. Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis[J].Eur J Intern Med,2022,104: 21. |
39 | Praktiknjo M, Trebicka J, Carnevale R, et al. Von willebrand and factor Ⅶ Ⅰ portosystemic circulation gradient in cirrhosis: implications for portal vein thrombosis[J].Clin Transl Gastroenterol,2020,11(2): e00123. |
40 | de Franchis R, Faculty BV. Revising consensus in portal hypertension: report of the Baveno Ⅴ consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].J Hepatol,2010,53(4): 762. |
41 | Xu XB, Guo XZ, De Stefano V, et al. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis[J].Hepatol Int,2019,13(4): 468. |
42 | Wu LF, Bai DS, Shi L, et al. Predictors of portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection in hepatitis B cirrhosis: a prospective study[J].Surg Endosc,2022,36(6): 4090. |
[1] | 赵思薇, 柴杰, 王永胜.细胞焦亡发生机制及与胃癌关系的研究进展[J]. betway必威登陆网址 (betway.com )学报, 2024, 45(4): 231-235. |
[2] | 李彬, 冯锋, 刘富垒.肿瘤切除手术诱发术后复发的机制及纠正策略研究进展[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(7): 535-540. |
[3] | 董柏萍, 王永生, 吕静静, 韩燕珍, 袁锁伟, 梁永, 毛蕾蕾.基于微小RNA‐146a探究川陈皮素对帕金森病模型的神经保护作用[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(4): 254-259. |
[4] | 周谦, 邵一兵, 牛兆倬, 毕晓磊.冠状动脉周围脂肪与冠脉动脉粥样硬化[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(4): 304-312. |
[5] | 王朔, 赵作勤, 张古泉, 张永丽.柿叶黄酮的镇痛抗炎作用及对口腔溃疡大鼠p38MAPK和MMP2/9的调控作用[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(3): 197-201. |
[6] | 陈琪, 韩丽萍.慢性阻塞性肺疾病血清炎症标志物的研究进展[J]. betway必威登陆网址 (betway.com )学报, 2023, 44(12): 950-954. |
[7] | 王宜君, 唐样, 江益凡, 耿志军, 宋雪.RIP激酶家族影响炎症性肠病机制的研究进展[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(3): 3-3. |
[8] | 潘天琦, 田华, 姚树桐.细胞焦亡与自噬的相互关系及其在动脉粥样硬化发生发展中的作用[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(2): 156-160. |
[9] | 廖杰, 杜以梅.术后心房颤动发病机制的研究进展[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(12): 891-896. |
[10] | 张倩, 谢永刚, 马加海, 张建中.6%羟乙基淀粉130/0.4对创伤性蛋白微血管渗漏影响的研究进展[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(11): 856-859. |
[11] | 聂翠芳, 赵传芸, 杨圣强.特利加压素联合托伐普坦治疗乙型肝炎肝硬化并发肝肾综合征的疗效[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(10): 770-773. |
[12] | 胡世丰.血清MK及bFGF联合测定对胃癌术后复发的预测价值[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(1): 45-49. |
[13] | 韦忠丽.通腑消毒饮灌肠、外敷联合埃索美拉唑对重症急性胰腺炎患者肠黏膜屏障功能、炎症状态的影响[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(8): 602-605. |
[14] | 徐子龙, 耿志军, 李静.粪菌移植在肠道疾病临床应用中的研究进展[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(7): 551-555. |
[15] | 赵梦秋, 任尤楠, 陶善珺, 郑书国.丹酚酸B改善糖尿病血糖波动模型大鼠心肌损伤的作用[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(5): 369-374. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||